anmelden
SPI
18.684,24
PKT
+101,75
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.06.17 | Roche overweight | JP Morgan Chase & Co. | |
| 27.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 27.06.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 27.06.17 | Nestlé buy | S&P Capital IQ | |
| 26.06.17 | UBS overweight | JP Morgan Chase & Co. | |
| 26.06.17 | UBS overweight | JP Morgan Chase & Co. | |
| 23.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.06.17 | Novartis Equal weight | Barclays Capital | |
| 23.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.06.17 | Novartis buy | Jefferies & Company Inc. | |
| 22.06.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 22.06.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 22.06.17 | UBS buy | HSBC | |
| 21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.06.17 | Novartis Hold | Deutsche Bank AG | |
| 21.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 21.06.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 21.06.17 | Holcim Neutral | JP Morgan Chase & Co. | |
| 21.06.17 | Novartis buy | HSBC | |
| 20.06.17 | Nestlé buy | Citigroup Corp. | |
| 20.06.17 | UBS overweight | Morgan Stanley | |
| 20.06.17 | UBS overweight | Morgan Stanley | |
| 20.06.17 | Swiss Re buy | Deutsche Bank AG | |
| 20.06.17 | Roche Neutral | BNP PARIBAS | |
| 19.06.17 | Swiss Re Sell | UBS AG | |
| 19.06.17 | UBS buy | Citigroup Corp. | |
| 19.06.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 19.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.06.17 | Nestlé overweight | Morgan Stanley | |
| 16.06.17 | Roche buy | Jefferies & Company Inc. | |
| 16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 16.06.17 | Holcim buy | S&P Capital IQ | |
| 15.06.17 | Nestlé Underperform | Credit Suisse Group | |
| 15.06.17 | UBS Sell | S&P Capital IQ | |
| 15.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 15.06.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 15.06.17 | Nestlé buy | S&P Capital IQ | |
| 14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 13.06.17 | UBS overweight | Morgan Stanley | |
| 13.06.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley |